Cargando…
New Synthetic Opioids: Clinical Considerations and Dangers
Since the early 2010s, synthetic opioids have significantly contributed to overall opioid-related overdose mortalities. For point of reference, of the 68,630 opioid-related deaths recorded in 2020, 56,516 involved synthetic opioids. During much of this period, fentanyl has been the most commonly use...
Autores principales: | Edinoff, Amber N., Martinez Garza, David, Vining, Stephen P., Vasterling, Megan E., Jackson, Eric D., Murnane, Kevin S., Kaye, Adam M., Fair, Richard N., Torres, Yair Jose Lopez, Badr, Ahmed E., Cornett, Elyse M., Kaye, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950705/ https://www.ncbi.nlm.nih.gov/pubmed/36826742 http://dx.doi.org/10.1007/s40122-023-00481-6 |
Ejemplares similares
-
Benzodiazepines: Uses, Dangers, and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021) -
Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging
por: Murnane, Kevin S, et al.
Publicado: (2023) -
Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021) -
Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review
por: Edinoff, Amber N., et al.
Publicado: (2023) -
Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)